Benefits in Cognitive Function, Blood Pressure, and Insulin Resistance Through Cocoa Flavanol Consumption in Elderly Subjects With Mild Cognitive Impairment: The Cocoa, Cognition, and Aging (CoCoA) Study
Abstract
Flavanol consumption is favorably associated with cognitive function. We tested the hypothesis that dietary flavanols might improve cognitive function in subjects with mild cognitive impairment. We conducted a double-blind, parallel arm study in 90 elderly individuals with mild cognitive impairment randomized to consume once daily for 8 weeks a drink containing ≈990 mg (high flavanols), ≈520 mg (intermediate flavanols), or ≈45 mg (low flavanols) of cocoa flavanols per day. Cognitive function was assessed by Mini Mental State Examination, Trail Making Test A and B, and verbal fluency test. At the end of the follow-up period, Mini Mental State Examination was similar in the 3 treatment groups ( P =0.13). The time required to complete Trail Making Test A and Trail Making Test B was significantly ( P <0.05) lower in subjects assigned to high flavanols (38.10±10.94 and 104.10±28.73 seconds, respectively) and intermediate flavanols (40.20±11.35 and 115.97±28.35 seconds, respectively) in comparison with those assigned to low flavanols (52.60±17.97 and 139.23±43.02 seconds, respectively). Similarly, verbal fluency test score was significantly ( P <0.05) better in subjects assigned to high flavanols in comparison with those assigned to low flavanols (27.50±6.75 versus 22.30±8.09 words per 60 seconds). Insulin resistance, blood pressure, and lipid peroxidation also decreased among subjects in the high-flavanol and intermediate-flavanol groups. Changes of insulin resistance explained ≈40% of composite z score variability through the study period (partial r 2 =0.4013; P <0.0001). To the best of our knowledge, this is the first dietary intervention study demonstrating that the regular consumption of cocoa flavanols might be effective in improving cognitive function in elderly subjects with mild cognitive impairment. This effect appears mediated in part by an improvement in insulin sensitivity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 99 cited sources checked · 0 supported · 0 flagged
- Findingown data
TMT A time decreased significantly in the HF group (mean change -14.3±4.2 s; P<0.0001).
“The time required to complete TMT A significantly changed throughout the study period (PϽ0.0001), with significant reductions observed in subjects assigned to HF (Ϫ14.3Ϯ4.2 seconds; PϽ0.0001) and IF (Ϫ8.8Ϯ3.4 seconds; PϽ0.0001) interventions but not in those assigned to the LF intervention (ϩ1.1Ϯ13.0seconds; Pϭ0.65; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
TMT A completion time significantly changed over the study period (P<0.0001).
“The time required to complete TMT A significantly changed throughout the study period (PϽ0.0001), with significant reductions observed in subjects assigned to HF (Ϫ14.3Ϯ4.2 seconds; PϽ0.0001) and IF (Ϫ8.8Ϯ3.4 seconds; PϽ0.0001) interventions but not in those assigned to the LF intervention (ϩ1.1Ϯ13.0seconds; Pϭ0.65; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
TMT A time decreased significantly in the IF group (mean change -8.8±3.4 s; P<0.0001).
“The time required to complete TMT A significantly changed throughout the study period (PϽ0.0001), with significant reductions observed in subjects assigned to HF (Ϫ14.3Ϯ4.2 seconds; PϽ0.0001) and IF (Ϫ8.8Ϯ3.4 seconds; PϽ0.0001) interventions but not in those assigned to the LF intervention (ϩ1.1Ϯ13.0seconds; Pϭ0.65; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
MMSE score did not significantly change with treatment over the study period (P=0.13).
“Mini Mental State Examination score did not significantly change in relation to the 3 different treatments during the study period (Pϭ0.13;Table 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
Plasma glucose decreased significantly in HF group (-0.6±0.3 mmol/L; P<0.0001).
“Plasma glucose levels significantly changed during the study period (PϽ0.0001), with significant reductions observed in subjects assigned to HF (Ϫ0.6Ϯ0.3 mmol/L; PϽ0.0001) and IF (Ϫ0.5Ϯ0.1 mmol/L; PϽ0.0001) but not in those assigned to LF (Ϫ0.1Ϯ0.5 mmol/L; Pϭ0.19; Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Composite cognitive z score significantly changed over the study period (P<0.0001).
“According to the above results, the composite cognitive z score significantly changed during the study period (PϽ0.0001), with HF (ϩ0.693Ϯ0.223;PϽ0.0001) and IF (ϩ0.404Ϯ0.141;PϽ0.0001) groups demonstrating significant improvement; no change was observed in the LF group (Ϫ0.072Ϯ0.383;Pϭ0.31; Table 1 and Figure S2).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Table 1
Not checked in the free run.
- cites Figure S2
Not checked in the free run.
- Findingown data
At end of follow-up, composite z score was significantly better in HF than LF (P<0.05).
“Composite cognitive z score at the end of follow-up was significantly (PϽ0.05)better in subjects assigned to HF in comparison with those assigned to LF (Table 1 and Figure S2).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Table 1
Not checked in the free run.
- cites Figure S2
Not checked in the free run.
- Findingown data
At end of follow-up, systolic BP was lower in HF than LF (P<0.05).
“Thus, systolic and diastolic blood pressure levels at the end of follow-up were significantly (PϽ0.05)lower in subjects assigned to HF and IF in comparison with those assigned to LF (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
At end of follow-up, diastolic BP was lower in HF than LF (P<0.05).
“Thus, systolic and diastolic blood pressure levels at the end of follow-up were significantly (PϽ0.05)lower in subjects assigned to HF and IF in comparison with those assigned to LF (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
VFT score improved significantly in HF group (+8.0±5.3 words/60s; P<0.0001).
“Verbal fluency test scores significantly improved (PϽ0.0001) in the study, again with improvements demonstrated in the HF (ϩ8.0Ϯ5.3 words per 60 seconds; PϽ0.0001) and IF (ϩ5.1Ϯ3.1 words per 60 seconds; PϽ0.0001) groups and, to a lesser extent, in those assigned to the LF group (ϩ1.2Ϯ2.7 words per 60 seconds; Pϭ0.014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
At end of follow-up, systolic BP was lower in IF than LF (P<0.05).
“Thus, systolic and diastolic blood pressure levels at the end of follow-up were significantly (PϽ0.05)lower in subjects assigned to HF and IF in comparison with those assigned to LF (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
At end of follow-up, TMT B time was significantly lower in IF than LF (P<0.05).
“Thus, TMT A and TMT B scores at the end of follow-up were significantly (PϽ0.05)better in subjects assigned to HF and IF treatments in comparison with those assigned to the LF group (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
TMT A time did not change significantly in the LF group (mean change +1.1±13.0 s; P=0.65).
“The time required to complete TMT A significantly changed throughout the study period (PϽ0.0001), with significant reductions observed in subjects assigned to HF (Ϫ14.3Ϯ4.2 seconds; PϽ0.0001) and IF (Ϫ8.8Ϯ3.4 seconds; PϽ0.0001) interventions but not in those assigned to the LF intervention (ϩ1.1Ϯ13.0seconds; Pϭ0.65; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
Systolic BP decreased significantly in IF group (-8.2±3.5 mm Hg; P<0.0001).
“Systolic and diastolic blood pressures significantly (PϽ0.0001)changed through the study period with significant pressure reductions among HF (systolic: Ϫ10.0Ϯ3.1 mm Hg, PϽ0.0001; diastolic: Ϫ4.8Ϯ1.8 mm Hg, PϽ0.0001) and IF (systolic: Ϫ8.2Ϯ3.5 mm Hg, PϽ0.0001; diastolic: Ϫ3.4Ϯ2.0 mm Hg, PϽ0.0001) subjects but not in those assigned to the LF group (systolic: Ϫ1.4Ϯ5.4 mm Hg, Pϭ0.16; diastolic: Ϫ0.9Ϯ”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Diastolic BP did not change significantly in LF group (-0.9±3.4 mm Hg; P=0.14).
“Systolic and diastolic blood pressures significantly (PϽ0.0001)changed through the study period with significant pressure reductions among HF (systolic: Ϫ10.0Ϯ3.1 mm Hg, PϽ0.0001; diastolic: Ϫ4.8Ϯ1.8 mm Hg, PϽ0.0001) and IF (systolic: Ϫ8.2Ϯ3.5 mm Hg, PϽ0.0001; diastolic: Ϫ3.4Ϯ2.0 mm Hg, PϽ0.0001) subjects but not in those assigned to the LF group (systolic: Ϫ1.4Ϯ5.4 mm Hg, Pϭ0.16; diastolic: Ϫ0.9Ϯ”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
TMT B time decreased significantly in HF group (-29.2±8.0 s; P<0.0001).
“Similarly, the time required to complete TMT B significantly changed during the study period (PϽ0.0001), with significant reductions observed among HF (Ϫ29.2Ϯ8.0 seconds; PϽ0.0001) and IF (Ϫ22.8Ϯ5.1 second; PϽ0.0001) subjects but not in those assigned to the LF intervention (ϩ3.8Ϯ16.3seconds; Pϭ0.21; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
VFT score improved significantly in IF group (+5.1±3.1 words/60s; P<0.0001).
“Verbal fluency test scores significantly improved (PϽ0.0001) in the study, again with improvements demonstrated in the HF (ϩ8.0Ϯ5.3 words per 60 seconds; PϽ0.0001) and IF (ϩ5.1Ϯ3.1 words per 60 seconds; PϽ0.0001) groups and, to a lesser extent, in those assigned to the LF group (ϩ1.2Ϯ2.7 words per 60 seconds; Pϭ0.014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
Plasma glucose significantly changed over study period (P<0.0001).
“Plasma glucose levels significantly changed during the study period (PϽ0.0001), with significant reductions observed in subjects assigned to HF (Ϫ0.6Ϯ0.3 mmol/L; PϽ0.0001) and IF (Ϫ0.5Ϯ0.1 mmol/L; PϽ0.0001) but not in those assigned to LF (Ϫ0.1Ϯ0.5 mmol/L; Pϭ0.19; Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Diastolic BP decreased significantly in HF group (-4.8±1.8 mm Hg; P<0.0001).
“Systolic and diastolic blood pressures significantly (PϽ0.0001)changed through the study period with significant pressure reductions among HF (systolic: Ϫ10.0Ϯ3.1 mm Hg, PϽ0.0001; diastolic: Ϫ4.8Ϯ1.8 mm Hg, PϽ0.0001) and IF (systolic: Ϫ8.2Ϯ3.5 mm Hg, PϽ0.0001; diastolic: Ϫ3.4Ϯ2.0 mm Hg, PϽ0.0001) subjects but not in those assigned to the LF group (systolic: Ϫ1.4Ϯ5.4 mm Hg, Pϭ0.16; diastolic: Ϫ0.9Ϯ”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Composite z score improved significantly in HF group (+0.693±0.223; P<0.0001).
“According to the above results, the composite cognitive z score significantly changed during the study period (PϽ0.0001), with HF (ϩ0.693Ϯ0.223;PϽ0.0001) and IF (ϩ0.404Ϯ0.141;PϽ0.0001) groups demonstrating significant improvement; no change was observed in the LF group (Ϫ0.072Ϯ0.383;Pϭ0.31; Table 1 and Figure S2).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Table 1
Not checked in the free run.
- cites Figure S2
Not checked in the free run.
- Findingown data
TMT B time decreased significantly in IF group (-22.8±5.1 s; P<0.0001).
“Similarly, the time required to complete TMT B significantly changed during the study period (PϽ0.0001), with significant reductions observed among HF (Ϫ29.2Ϯ8.0 seconds; PϽ0.0001) and IF (Ϫ22.8Ϯ5.1 second; PϽ0.0001) subjects but not in those assigned to the LF intervention (ϩ3.8Ϯ16.3seconds; Pϭ0.21; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
Systolic BP decreased significantly in HF group (-10.0±3.1 mm Hg; P<0.0001).
“Systolic and diastolic blood pressures significantly (PϽ0.0001)changed through the study period with significant pressure reductions among HF (systolic: Ϫ10.0Ϯ3.1 mm Hg, PϽ0.0001; diastolic: Ϫ4.8Ϯ1.8 mm Hg, PϽ0.0001) and IF (systolic: Ϫ8.2Ϯ3.5 mm Hg, PϽ0.0001; diastolic: Ϫ3.4Ϯ2.0 mm Hg, PϽ0.0001) subjects but not in those assigned to the LF group (systolic: Ϫ1.4Ϯ5.4 mm Hg, Pϭ0.16; diastolic: Ϫ0.9Ϯ”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Verbal fluency test scores significantly improved over the study (P<0.0001).
“Verbal fluency test scores significantly improved (PϽ0.0001) in the study, again with improvements demonstrated in the HF (ϩ8.0Ϯ5.3 words per 60 seconds; PϽ0.0001) and IF (ϩ5.1Ϯ3.1 words per 60 seconds; PϽ0.0001) groups and, to a lesser extent, in those assigned to the LF group (ϩ1.2Ϯ2.7 words per 60 seconds; Pϭ0.014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
Diastolic BP decreased significantly in IF group (-3.4±2.0 mm Hg; P<0.0001).
“Systolic and diastolic blood pressures significantly (PϽ0.0001)changed through the study period with significant pressure reductions among HF (systolic: Ϫ10.0Ϯ3.1 mm Hg, PϽ0.0001; diastolic: Ϫ4.8Ϯ1.8 mm Hg, PϽ0.0001) and IF (systolic: Ϫ8.2Ϯ3.5 mm Hg, PϽ0.0001; diastolic: Ϫ3.4Ϯ2.0 mm Hg, PϽ0.0001) subjects but not in those assigned to the LF group (systolic: Ϫ1.4Ϯ5.4 mm Hg, Pϭ0.16; diastolic: Ϫ0.9Ϯ”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
At end of follow-up, TMT B time was significantly lower in HF than LF (P<0.05).
“Thus, TMT A and TMT B scores at the end of follow-up were significantly (PϽ0.05)better in subjects assigned to HF and IF treatments in comparison with those assigned to the LF group (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
TMT B time did not change significantly in LF group (+3.8±16.3 s; P=0.21).
“Similarly, the time required to complete TMT B significantly changed during the study period (PϽ0.0001), with significant reductions observed among HF (Ϫ29.2Ϯ8.0 seconds; PϽ0.0001) and IF (Ϫ22.8Ϯ5.1 second; PϽ0.0001) subjects but not in those assigned to the LF intervention (ϩ3.8Ϯ16.3seconds; Pϭ0.21; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
Systolic BP did not change significantly in LF group (-1.4±5.4 mm Hg; P=0.16).
“Systolic and diastolic blood pressures significantly (PϽ0.0001)changed through the study period with significant pressure reductions among HF (systolic: Ϫ10.0Ϯ3.1 mm Hg, PϽ0.0001; diastolic: Ϫ4.8Ϯ1.8 mm Hg, PϽ0.0001) and IF (systolic: Ϫ8.2Ϯ3.5 mm Hg, PϽ0.0001; diastolic: Ϫ3.4Ϯ2.0 mm Hg, PϽ0.0001) subjects but not in those assigned to the LF group (systolic: Ϫ1.4Ϯ5.4 mm Hg, Pϭ0.16; diastolic: Ϫ0.9Ϯ”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
At the end of follow-up, TMT A time was significantly lower in HF than LF (P<0.05).
“Thus, TMT A and TMT B scores at the end of follow-up were significantly (PϽ0.05)better in subjects assigned to HF and IF treatments in comparison with those assigned to the LF group (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
TMT B completion time significantly changed over the study period (P<0.0001).
“Similarly, the time required to complete TMT B significantly changed during the study period (PϽ0.0001), with significant reductions observed among HF (Ϫ29.2Ϯ8.0 seconds; PϽ0.0001) and IF (Ϫ22.8Ϯ5.1 second; PϽ0.0001) subjects but not in those assigned to the LF intervention (ϩ3.8Ϯ16.3seconds; Pϭ0.21; Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
Composite z score did not change in LF group (-0.072±0.383; P=0.31).
“According to the above results, the composite cognitive z score significantly changed during the study period (PϽ0.0001), with HF (ϩ0.693Ϯ0.223;PϽ0.0001) and IF (ϩ0.404Ϯ0.141;PϽ0.0001) groups demonstrating significant improvement; no change was observed in the LF group (Ϫ0.072Ϯ0.383;Pϭ0.31; Table 1 and Figure S2).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Table 1
Not checked in the free run.
- cites Figure S2
Not checked in the free run.
- Findingown data
At the end of follow-up, TMT A time was significantly lower in IF than LF (P<0.05).
“Thus, TMT A and TMT B scores at the end of follow-up were significantly (PϽ0.05)better in subjects assigned to HF and IF treatments in comparison with those assigned to the LF group (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
VFT score improved significantly in LF group to a lesser extent (+1.2±2.7 words/60s; P=0.014).
“Verbal fluency test scores significantly improved (PϽ0.0001) in the study, again with improvements demonstrated in the HF (ϩ8.0Ϯ5.3 words per 60 seconds; PϽ0.0001) and IF (ϩ5.1Ϯ3.1 words per 60 seconds; PϽ0.0001) groups and, to a lesser extent, in those assigned to the LF group (ϩ1.2Ϯ2.7 words per 60 seconds; Pϭ0.014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
Composite z score improved significantly in IF group (+0.404±0.141; P<0.0001).
“According to the above results, the composite cognitive z score significantly changed during the study period (PϽ0.0001), with HF (ϩ0.693Ϯ0.223;PϽ0.0001) and IF (ϩ0.404Ϯ0.141;PϽ0.0001) groups demonstrating significant improvement; no change was observed in the LF group (Ϫ0.072Ϯ0.383;Pϭ0.31; Table 1 and Figure S2).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Table 1
Not checked in the free run.
- cites Figure S2
Not checked in the free run.
- Findingown data
Improvement in VFT score was significantly greater in HF than LF (P<0.05).
“The improvement of verbal fluency test score was significantly (PϽ0.05)greater in HF subjects in comparison with those assigned to the LF group (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
- Findingown data
At end of follow-up, diastolic BP was lower in IF than LF (P<0.05).
“Thus, systolic and diastolic blood pressure levels at the end of follow-up were significantly (PϽ0.05)lower in subjects assigned to HF and IF in comparison with those assigned to LF (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Systolic and diastolic blood pressures significantly changed over the study period (P<0.0001).
“Systolic and diastolic blood pressures significantly (PϽ0.0001)changed through the study period with significant pressure reductions among HF (systolic: Ϫ10.0Ϯ3.1 mm Hg, PϽ0.0001; diastolic: Ϫ4.8Ϯ1.8 mm Hg, PϽ0.0001) and IF (systolic: Ϫ8.2Ϯ3.5 mm Hg, PϽ0.0001; diastolic: Ϫ3.4Ϯ2.0 mm Hg, PϽ0.0001) subjects but not in those assigned to the LF group (systolic: Ϫ1.4Ϯ5.4 mm Hg, Pϭ0.16; diastolic: Ϫ0.9Ϯ”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Changes in HOMA-IR were the main determinants of cognitive changes, explaining about 40% of composite z score variability (r2=0.4013, β=-0.2910; P<0.0001).
“Changes of HOMA-IR were found to be the main determinants of changes in cognitive function, explaining Ϸ40% of composite z score variability through the study period (r 2 ϭ0.4013, ϭϪ0.2910;PϽ0.0001; Table S4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table S4
Not checked in the free run.
- Findingown data
At end, plasma glucose was lower in HF than LF (P<0.05).
“Thus, plasma glucose levels at the end of follow-up were significantly (PϽ0.05)lower in subjects assigned to HF and IF in comparison with those assigned to LF (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
HOMA-IR significantly improved over study period (P<0.0001).
“HOMA-IR significantly improved through the study period (PϽ0.0001), with significant reductions in subjects assigned to HF (Ϫ1.6Ϯ1.0;PϽ0.0001) and IF (Ϫ0.9Ϯ0.2;PϽ0.0001) but not in those assigned to LF (Ϫ0.1Ϯ0.5;Pϭ0.29; Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
8-iso-PGF2α did not change significantly in LF group (-3.6±51.4 pg/L; P=0.71).
“Plasma total 8-iso-PGF 2␣ levels significantly decreased during the study period (PϽ0.0001), with significant reductions observed among subjects assigned to HF (Ϫ99.8Ϯ60.3pg/L; PϽ0.0001) and IF (Ϫ65.2Ϯ87.2pg/L; Pϭ0.0003), but not in those assigned to LF (Ϫ3.6Ϯ51.4pg/L; Pϭ0.71) drinks (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Plasma total 8-iso-PGF2α significantly decreased over study period (P<0.0001).
“Plasma total 8-iso-PGF 2␣ levels significantly decreased during the study period (PϽ0.0001), with significant reductions observed among subjects assigned to HF (Ϫ99.8Ϯ60.3pg/L; PϽ0.0001) and IF (Ϫ65.2Ϯ87.2pg/L; Pϭ0.0003), but not in those assigned to LF (Ϫ3.6Ϯ51.4pg/L; Pϭ0.71) drinks (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Plasma glucose decreased significantly in IF group (-0.5±0.1 mmol/L; P<0.0001).
“Plasma glucose levels significantly changed during the study period (PϽ0.0001), with significant reductions observed in subjects assigned to HF (Ϫ0.6Ϯ0.3 mmol/L; PϽ0.0001) and IF (Ϫ0.5Ϯ0.1 mmol/L; PϽ0.0001) but not in those assigned to LF (Ϫ0.1Ϯ0.5 mmol/L; Pϭ0.19; Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
8-iso-PGF2α decreased significantly in IF group (-65.2±87.2 pg/L; P=0.0003).
“Plasma total 8-iso-PGF 2␣ levels significantly decreased during the study period (PϽ0.0001), with significant reductions observed among subjects assigned to HF (Ϫ99.8Ϯ60.3pg/L; PϽ0.0001) and IF (Ϫ65.2Ϯ87.2pg/L; Pϭ0.0003), but not in those assigned to LF (Ϫ3.6Ϯ51.4pg/L; Pϭ0.71) drinks (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
HOMA-IR decreased significantly in IF group (-0.9±0.2; P<0.0001).
“HOMA-IR significantly improved through the study period (PϽ0.0001), with significant reductions in subjects assigned to HF (Ϫ1.6Ϯ1.0;PϽ0.0001) and IF (Ϫ0.9Ϯ0.2;PϽ0.0001) but not in those assigned to LF (Ϫ0.1Ϯ0.5;Pϭ0.29; Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
No significant differences in plasma insulin levels were found among the three treatment groups at end of follow-up.
“With regard to plasma insulin levels, no significant differences were found among the 3 treatment groups at the end of follow-up (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingreasoning
Cocoa flavanols had no effect on the Mini Mental State Examination score.
“On the other hand, the lack of an effect of flavanols on the Mini Mental State Examination score is likely a reflection of the low sensitivity of this test to detect small changes at the upper end of cognitive performance over time.”
Quote in the paperNot a substantial claim - Findingown data
There was an independent negative relationship between changes in composite cognitive z score and changes in HOMA-IR, which explained about 40% of the variation in composite cognitive z score over the study period.
“We found an independent negative relationship between changes in composite cognitive z score and change in HOMA-IR, which explained Ϸ40% of composite cognitive z score variation throughout the study period.”
Quote in the paperSubstantial claim - Findingown data
8-iso-PGF2α decreased significantly in HF group (-99.8±60.3 pg/L; P<0.0001).
“Plasma total 8-iso-PGF 2␣ levels significantly decreased during the study period (PϽ0.0001), with significant reductions observed among subjects assigned to HF (Ϫ99.8Ϯ60.3pg/L; PϽ0.0001) and IF (Ϫ65.2Ϯ87.2pg/L; Pϭ0.0003), but not in those assigned to LF (Ϫ3.6Ϯ51.4pg/L; Pϭ0.71) drinks (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
At end, 8-iso-PGF2α was significantly lower in HF than LF (P<0.05).
“Thus, plasma total 8-iso-PGF 2␣ levels at the end of follow-up were significantly (PϽ0.05)lower in subjects assigned to HF in comparison with those assigned to LF (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
HOMA-IR decreased significantly in HF group (-1.6±1.0; P<0.0001).
“HOMA-IR significantly improved through the study period (PϽ0.0001), with significant reductions in subjects assigned to HF (Ϫ1.6Ϯ1.0;PϽ0.0001) and IF (Ϫ0.9Ϯ0.2;PϽ0.0001) but not in those assigned to LF (Ϫ0.1Ϯ0.5;Pϭ0.29; Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
At end, plasma glucose was lower in IF than LF (P<0.05).
“Thus, plasma glucose levels at the end of follow-up were significantly (PϽ0.05)lower in subjects assigned to HF and IF in comparison with those assigned to LF (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Plasma glucose did not change significantly in LF group (-0.1±0.5 mmol/L; P=0.19).
“Plasma glucose levels significantly changed during the study period (PϽ0.0001), with significant reductions observed in subjects assigned to HF (Ϫ0.6Ϯ0.3 mmol/L; PϽ0.0001) and IF (Ϫ0.5Ϯ0.1 mmol/L; PϽ0.0001) but not in those assigned to LF (Ϫ0.1Ϯ0.5 mmol/L; Pϭ0.19; Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Changes in plasma glucose and HOMA-IR during the study correlated with their baseline values in the whole population (r=-0.325, P=0.0018; r=-0.421, P<0.0001).
“Spearman nonparametric correlation revealed significant relationships between changes of plasma glucose and HOMA-IR during the study period and their respective values at baseline (rϭϪ0.325,Pϭ0.0018 and rϭϪ0.421 and PϽ0.0001, respectively) in the study population considered as a whole.”
Quote in the paperNot a substantial claim - Findingown data
HOMA-IR did not change significantly in LF group (-0.1±0.5; P=0.29).
“HOMA-IR significantly improved through the study period (PϽ0.0001), with significant reductions in subjects assigned to HF (Ϫ1.6Ϯ1.0;PϽ0.0001) and IF (Ϫ0.9Ϯ0.2;PϽ0.0001) but not in those assigned to LF (Ϫ0.1Ϯ0.5;Pϭ0.29; Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
At end, HOMA-IR was significantly better in HF than LF (P<0.05).
“HOMA-IR at the end of follow-up was significantly (PϽ0.05)better in subjects assigned to HF in comparison with those assigned to LF (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Findingown data
Cognitive improvements were already apparent at an intermediate level of cocoa flavanol intake.
“Interestingly, these improvements were already evident at an intermediate cocoa flavanol content, suggesting a particular sensitivity of this subset of neuropsychological functions to the benefits of cocoa flavanols.”
Quote in the paperSubstantial claim - Findingown data
In participants assigned to the high-flavanol cocoa drink, verbal fluency test performance improved significantly.
“According to the above findings, a significant improvement in performance in the verbal fluency test, a test commonly used as a measure of executive function and language, was also observed in subjects assigned to HF consumption.”
Quote in the paperSubstantial claim - Findingown data
Blood pressure changes explained 2% or less of the cognitive improvement over the study period.
“Our findings seem to exclude any relevant contribution of blood pressure reduction to the variations of cognitive performance after 8 weeks of cocoa flavanol consumption, because blood pressure changes explained Յ2% of cognitive improvement throughout the study period.”
Quote in the paperSubstantial claim - Findingown data
Flavanol-rich cocoa consumption significantly reduced circulating plasma F2-isoprostane levels.
“The last interesting finding of our study was the significant reduction of circulating levels of plasma F2-isoprostanes after flavanol-rich cocoa consumption.”
Quote in the paperNot a substantial claim - Study design and conductown data
Baseline blood pressure and metabolic parameters were similar across the three treatment groups.
“Baseline blood pressure levels and metabolic parameters were similar for the 3 treatment groups (Table 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
- Interpretationreasoning
This study alone cannot determine the effective flavanol amount needed to improve or maintain cognition.
“However, our study is the first well-controlled trial that addresses the relationship between cocoa flavanols and cognitive function, and from this study alone, we cannot say what is the effective flavanol amount that is required to improve or maintain cognition.”
Quote in the paperSubstantial claim - Interpretationown data
Insulin resistance may play an influential role in modulating cognitive function in subjects with early memory decline.
“These data suggest a possible influential role of insulin-resistance in modulating cognitive function in subjects with early memory decline.”
Quote in the paperSubstantial claim - Premisecitation
The flavanol levels used in this study are comparable to those in earlier studies that found improvements in brain blood flow, vascular function, and blood pressure.
“In this regard, the level of flavanols used in this current study is comparable to the level of cocoa flavanols fed in previous studies where improvements in brain blood flow, 19 vascular function, and blood pressure were observed.25”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19]
Not checked in the free run.
- cites [25] source
Not checked in the free run.
- Premisecitation
In the MCI phase, interventional therapy could have the greatest potential to improve cognitive performance and slow disease progression.
“MCI represents an interesting field of research, because MCI increases the risk of later developing dementia, and, in this phase, an interventional therapy could have the greatest potential to improve cognitive performance and to slow down disease progression.3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] source
Not checked in the free run.
- Premisecitation
Substantial evidence supports a link between cognition and cardiovascular risk factors.
“Substantial evidence exists supporting the link between cognition and cardiovascular risk factors.10”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] source
Not checked in the free run.
- Premisecitation
MCI increases the risk of later developing dementia.
“MCI represents an interesting field of research, because MCI increases the risk of later developing dementia, and, in this phase, an interventional therapy could have the greatest potential to improve cognitive performance and to slow down disease progression.3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] source
Not checked in the free run.
- Interpretationown data
The data do not provide definite information about possible mechanisms behind the observed beneficial effects.
“Our data do not provide definite information as to possible mechanisms underlying the observed beneficial effects, although some putative pathways can be considered.”
Quote in the paperNot a substantial claim - Interpretationown data
The effect of cocoa flavanols on cognitive function appears mediated in part by an improvement in insulin sensitivity.
“This effect appears mediated in part by an improvement in insulin sensitivity.”
- Also stated in: § Additional information · hedged
“This effect appears mediated in part by an improvement in insulin sensitivity.”
Quote in the paperSubstantial claim - Also stated in: § Additional information · hedged
- Interpretationown data
This is the first dietary intervention study showing that regular cocoa flavanol consumption may improve cognitive function in elderly people with mild cognitive impairment.
“To the best of our knowledge, this is the first dietary intervention study demonstrating that the regular consumption of cocoa flavanols might be effective in improving cognitive function in elderly subjects with mild cognitive impairment.”
Quote in the paperSubstantial claim- Rests on an assumption: No dietary intervention study had yet specifically investigated neurocognitive performance in response to dietary flavanols in subjects with MCI.
- Interpretationown data
The current study provides the first evidence that regular cocoa flavanol consumption can positively affect cognitive function in older adults with early memory decline.
“The current study sheds new light on this relevant topic, providing the first evidence that regular cocoa flavanol consumption can positively affect cognitive function in older adults with early memory decline.”
Quote in the paperSubstantial claim- Rests on an assumption: No dietary intervention study had yet specifically investigated neurocognitive performance in response to dietary flavanols in subjects with MCI.
- Premisereasoning
The previously reported effects provide a strong foundation for the idea that regular flavanol consumption may have implications for cognitive function, particularly among those at risk.
“Taken together, these previously reported effects provide a strong foundation for the idea that the regular consumption of flavanols may have implications for cognitive function, particular among those at risk.”
Quote in the paperNot a substantial claim - Premisecitation
A recent meta-analysis by Hooper et al. found consistent acute and chronic benefits of chocolate- and cocoa-derived flavanols on insulin resistance.
“This evidence fully fits with evidence from the recent meta-analysis by Hooper et al 25 indicating consistent acute and chronic benefits of chocolate-and cocoa-derived flavanols on insulin resistance.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hooper et al 25
Not checked in the free run.
- Interpretationreasoning
The absence of an MMSE effect is likely due to the test's low sensitivity to small changes at the upper end of cognitive performance over time.
“On the other hand, the lack of an effect of flavanols on the Mini Mental State Examination score is likely a reflection of the low sensitivity of this test to detect small changes at the upper end of cognitive performance over time.”
Quote in the paperSubstantial claim - Premisecitation
Previously published studies provide consistent evidence that flavanol consumption, directly or indirectly, can produce important improvements in insulin sensitivity.
“Although it is unclear the mechanism underlying this effect, these previously published studies provide consistent evidence that the consumption of flavanols, either directly or indirectly, can mediate important improvements in insulin sensitivity.”
Quote in the paperSubstantial claim - Interpretationown data
The subset of neuropsychological functions comprising processing speed, executive function, and working memory is particularly sensitive to cocoa flavanols.
“Interestingly, these improvements were already evident at an intermediate cocoa flavanol content, suggesting a particular sensitivity of this subset of neuropsychological functions to the benefits of cocoa flavanols.”
Quote in the paperSubstantial claim - Interpretationown data
The data suggest a possible clinical benefit from regularly including cocoa flavanol-containing foods in the diet of subjects with MCI.
“Taken together, these data are suggestive of a possible clinical benefit derived from the regular dietary inclusion of cocoa flavanol-containing foods in subjects with MCI.”
Quote in the paperSubstantial claim - Interpretationown data
Blood pressure reduction did not relevantly contribute to the variations in cognitive performance after eight weeks of cocoa flavanol consumption.
“Our findings seem to exclude any relevant contribution of blood pressure reduction to the variations of cognitive performance after 8 weeks of cocoa flavanol consumption, because blood pressure changes explained Յ2% of cognitive improvement throughout the study period.”
Quote in the paperSubstantial claim - Premisecitation
Evidence is mounting that managing high blood pressure and other conventional cardiovascular risk factors could favorably affect the clinical course of MCI.
“Indeed, evidence is mounting that the management of high blood pressure and other conventional cardiovascular risk factors could favorably affect the clinical course of MCI.3,32”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationown data
Regular cocoa flavanol consumption might be effective in improving cognitive function in elderly subjects with MCI.
“Regular consumption of cocoa flavanols might be effective in improving cognitive function in elderly subjects with MCI.”
Quote in the paperSubstantial claim - Interpretationreasoning
The reduction in F2-isoprostanes probably results from global cardiovascular effects of cocoa flavanols rather than a direct antioxidant effect.
“These effects probably represent the consequence of the global effects of these nutrients on the cardiovascular system rather then the expression of a direct effect of cocoa flavanol.”
Quote in the paperNot a substantial claim - Interpretationown data
Regular inclusion of flavanol-containing foods may be an effective dietary approach for improving some aspects of cognitive dysfunction in adults with MCI.
“In summary, the results of the current study provide encouraging evidence that the regular inclusion of flavanolcontaining foods may be an effective dietary approach for improving some aspects of cognitive dysfunction in adults with MCI.”
Quote in the paperSubstantial claim - Interpretationcitation
Improved brain perfusion could have contributed to the cognitive improvement in the study population.
“An improvement in brain perfusion could have also played a contributory role in the ameliorating cognitive performance in our study population.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The study population may not be completely representative of all subjects with MCI.
“Thus, our study population could be not completely representative of all subjects with MCI.”
Quote in the paperNot a substantial claim - Premisecitation
Another study found that two weeks of regular flavanol-rich cocoa consumption, at an intake close to the high-flavanol drinks used here, was associated with a significant increase in cerebral blood flow in healthy elderly.
“This hypothesis is supported by the findings of another study, which demonstrated that 2 weeks of regular flavanol-rich cocoa consumption, providing an intake of cocoa flavanols close to that of HF drinks used in our study, was associated with a significant increase of cerebral blood in healthy elderly.19”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19]
Not checked in the free run.
- Interpretationown data
The data support the hypothesis that regular consumption of cocoa flavanols may improve cognitive performance in MCI adults in a relatively short period of time.
“Our data seem to support the hypothesis that the regular consumption of cocoa flavanols may be able to improve cognitive performance in MCI adults in a relatively short period of time.”
Quote in the paperSubstantial claim
- The quote only partly states this claim. 2
- May combine two claims. 24
- Classified as probably not a substantial claim. 20
The quote only partly states this claim.
Findingown dataCocoa flavanol consumption significantly improved insulin resistance.
“In this regard, we found a significant improvement of insulin resistance after cocoa flavanol consumption.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNo significant differences in total cholesterol, LDL cholesterol, HDL cholesterol, or triglycerides were found among the three groups at end of follow-up.
“With regard to total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides concentrations, no significant differences were found among the 3 treatment groups at the end of follow-up (Table 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 2
Not checked in the free run.
May combine two claims.
Findingown dataAmong older adults with mild cognitive impairment, regular intake of cocoa flavanols for eight weeks produced significant gains on a neuropsychological test battery, primarily in executive function, and also in working memory, short-term memory, long-term episodic memory, processing speed, and global cognition.
“We found significant improvements in performance on a battery of neuropsychological tests mainly exploring executive function but also aspects of working memory, short-term memory, long-term episodic memory, processing speed, and global cognition, after 8 weeks of regular cocoa flavanol consumption.”
- Also stated in: § Additional information · boosted
“For the first time, regular cocoa flavanol consumption has been shown to positively affect cognitive function in older adults with early memory decline.”
Quote in the paperSubstantial claim- Also stated in: § Additional information · boosted
May combine two claims.
Findingown dataThe cognitive benefits were especially clear for processing speed, executive function, and working memory, as shown by improvements in TMT A and TMT B scores.
“In particular, the benefits were remarkably evident for processing speed, executive function, and working memory, as indicated by the improvement in TMT A and TMT B scores.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenSubjects enrolled in the study were generally in good health and without known cardiovascular disease.
“Finally, subjects enrolled in our study were generally in good health and without known cardiovascular disease.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRegular cocoa flavanol consumption significantly reduced both systolic and diastolic blood pressure.
“The current demonstration of significant reductions in both systolic and diastolic blood pressure levels after regular cocoa flavanol consumption is consistent with previous findings obtained both in normotensives and in hypertensive subjects, as well as medicated individuals.17,18,29,30”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataBaseline cognitive test performance was similar across the three treatment groups, indicating adequate randomization.
“Baseline performance on the cognitive function tests was similar for the 3 treatment groups, indicating an adequate randomization procedure (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe CoCoA study was an 8-week double-blind randomized parallel-arm trial in 90 elderly people with mild cognitive impairment.
“We conducted a double-blind, parallel arm study in 90 elderly individuals with mild cognitive impairment randomized to consume once daily for 8 weeks a drink containing Ϸ990 mg (high flavanols), Ϸ520 mg ( intermediate flavanols), or Ϸ45 mg (low flavanols) of cocoa flavanols per day.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataOverall compliance was 99.6% at week 4 and 99.4% at week 8, with no difference among the LF, IF, and HF interventions.
“The overall compliance was 99.6% at week 4 and 99.4% at week 8, without difference among the LF, IF, and HF interventions.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe planned sample of 90 subjects, 1:1:1 across groups, was calculated to give 90% power to detect a moderate effect size (Cohen d=0.40) on the global cognitive z score between HF and LF at alpha 0.05.
“Thus, the study was based on an estimated sample size of 90 subjects, with a ratio of 1:1:1 for the 3 treatment groups, which has been calculated to be adequate to achieve 90% power to detect a moderate effect size (Cohen dϭ0.40) with 2 degrees of freedom and an ␣ of 0.05 on the global cognitive z score between HF and LF.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataDietary total flavanol intake was similar across groups at enrollment and decreased similarly during the run-in period.
“Dietary total flavanol intake was also similar in the 3 study groups at enrollment and slightly decreased during the run-in period to a similar degree in all of the groups, a consequence of the dietary prescriptions (Table S3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table S3
Not checked in the free run.
May combine two claims.
Study design and conductown dataThe three cocoa drinks were designed to be indistinguishable in taste and appearance, calorically balanced, and similar in macronutrient, mineral, theobromine, and caffeine content, differing significantly only in cocoa flavanols.
“The dairy-based cocoa drinks used in this study were specially designed so that they were indistinguishable in taste and appearance, calorically balanced, and contained similar macronutrient, mineral, theobromine, and caffeine content, varying significantly only in the content of cocoa flavanols (Table S1, available in the online-only Data Supplement).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table S1
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe statistical analysis followed the intention-to-treat principle.
“The statistical analysis was conducted according to the intention-totreat principle.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataA composite cognitive z score was predefined and built by converting log-transformed raw test scores to standardized scores based on baseline means and pooled SDs of the whole population.
“As a predefined procedure, an integrated measure of overall cognitive function, composite cognitive z score, was also constructed for each participant by converting the logtransformed raw scores from the individual tests to standardized scores (z score) that were based on the means and pooled SDs of the whole population at baseline.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataNo significant differences in body weight or BMI were observed among the three groups at the end of follow-up.
“Furthermore, caloric intake was controlled throughout the study, because no significant differences in body weight (HF, 70.67Ϯ8.39kg; IF, 68.59Ϯ8.19kg; LF, 71.17Ϯ8.65 kg; Pϭ0.486) or body mass index (HF, 27.20Ϯ2.7 kg/m 2 ; IF, 26.27Ϯ2.50kg/m 2 ; LF, 26.90Ϯ2.75kg/m 2 ; Pϭ0.427) among the 3 study groups were observed at the end of follow-up.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe three groups were comparable in sex, age, anthropometric characteristics, cardiovascular risk factor prevalence, and pharmacological treatments.
“The 3 study groups were comparable with regard to sex, age, anthropometric characteristics, cardiovascular risk factor prevalence, and pharmacological treatments (Table S2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table S2
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataParticipants were randomly assigned to daily dairy-based cocoa drinks containing high, intermediate, or low cocoa flavanols for 8 weeks.
“After a 1-week run-in period, participants were randomly assigned to consume once daily a dairy-based cocoa drink containing cocoa flavanols either at a high (HF; Ϸ990 mg of flavanols per serving), intermediate (IF; Ϸ520 mg of flavanols per serving), or low level (LF; Ϸ45 mg of flavanols per serving) for 8 weeks.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataCognitive function was assessed with four well-validated standardized tests: MMSE, TMT A, TMT B, and verbal fluency.
“Cognitive testing was performed at baseline and after 8 weeks (Ϯ2 days) using a combination of 4 well-validated standardized tests: the Mini Mental State Examination, Trail Making Test (TMT) A, TMT B, and a verbal fluency test.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDietary flavanol consumption induces vasodilation of the peripheral and cerebral vascular system and increases brain blood flow and perfusion.
“In this regard, dietary flavanol consumption has been shown to reduce blood pressure and improve insulin sensitivity, 17,18 as well as to induce vasodilation of the peripheral 17,18 and cerebral vascular system, 19 increasing brain blood flow and perfusion.19,20”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims. The quote only partly states this claim.
Interpretationown dataCognitive performance improved with regular cocoa flavanol consumption without evidence of relevant adverse effects.
“We found that cognitive performance was improved with regular cocoa flavanol consumption without evidence of any relevant adverse effects.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataImprovement in cognitive performance was associated with a reduction in insulin resistance, suggesting a possible influential role of glucose metabolism in modulating cognitive function in these subjects.
“Interestingly, the improvement of cognitive performance was associated with a reduction in insulin resistance, suggesting a possible influential role of glucose metabolism in modulating cognitive function in these subjects.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDietary flavanol consumption has been shown to reduce blood pressure and improve insulin sensitivity.
“In this regard, dietary flavanol consumption has been shown to reduce blood pressure and improve insulin sensitivity, 17,18 as well as to induce vasodilation of the peripheral 17,18 and cerebral vascular system, 19 increasing brain blood flow and perfusion.19,20”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationHigh blood pressure has been linked with the pathophysiology of MCI and with Alzheimer disease and vascular dementia.
“In particular, high blood pressure has been linked with the pathophysiology of MCI other than with Alzheimer disease and vascular dementia.10,11”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFlavonoids have been reported to provide additional benefits to established hypoglycemic therapy in postmenopausal women with type 2 diabetes.
“Interestingly, flavonoids have been reported recently to exert additional benefits to established hypoglycemic therapy in postmenopausal type 2 diabetic patients.26”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAlterations in the insulin signaling pathway have been suggested as potential contributors to cognitive dysfunction.
“Alterations in the insulin signaling pathway have also been suggested as potential contributors to cognitive dysfunction because of the pivotal role of this hormone in modulating brain structure and function.[12][13][14]”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataRegular dietary inclusion of cocoa flavanols was associated with significant reductions in blood pressure and improvements in some metabolic markers.
“In addition to these cognitive improvements, the regular dietary inclusion of cocoa flavanols was associated with significant reductions in blood pressure, as well as in improvements in some metabolic markers.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe insulin sensitizer rosiglitazone could protect against cognitive decline in diabetic subjects with MCI.
“Supportive of this concept, it has been demonstrated recently that the insulin sensitizer rosiglitazone could protect against cognitive decline in diabetic subjects with MCI.27”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe blood pressure reductions are consistent with previous findings in normotensive, hypertensive, and medicated individuals.
“The current demonstration of significant reductions in both systolic and diastolic blood pressure levels after regular cocoa flavanol consumption is consistent with previous findings obtained both in normotensives and in hypertensive subjects, as well as medicated individuals.17,18,29,30”
Quote in the paperNot a substantial claim0 of 4 sources checkedMay combine two claims.
Interpretationown dataThe findings suggest that regular dietary inclusion of flavanols could be one element of a dietary approach to maintaining and improving cardiovascular health and specifically brain health.
“Although additional confirmatory studies are warranted, the findings reported herein suggest that the regular dietary inclusion of flavanols could be one element of a dietary approach to the maintaining and improving not only cardiovascular health but also specifically brain health.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIt is unclear whether the observed neurocognitive benefits are a direct consequence of cocoa flavanols or a secondary effect related to general improvements in cardiovascular function or health.
“Third, from pathophysiological perspective, it is yet unclear whether the observed benefits in neurocognition are a direct consequence of cocoa flavanol themselves or a secondary effect related to general improvements in cardiovascular function or health.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningCognitive testing used a battery of well-validated, standardized, and widely used neuropsychological tests, but these explored only some aspects of the complex cognitive dysfunction in MCI.
“First, because standard MCI criteria do not define optimal tests to establish cognitive performance in subjects with MCI, 22 cognitive testing was performed using a battery of well-validated, standardized, and widely used neuropsychological tests exploring only some aspects of the complex cognitive dysfunction in subjects with MCI.1,2”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningGeneral improvements in cardiovascular function and specific metabolic parameters could have, alone or in combination, played a role in improving cognitive performance in this study population.
“Other than the possible direct effects of flavanols on cognitive function, general improvements in cardiovascular function and specific metabolic parameters could have, alone or in combination, played a role in improving cognitive performance in this study population.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationF2-isoprostanes are generated from arachidonic acid through nonenzymatic free radical-catalyzed lipid peroxidation and are an established marker of oxidative stress.
“F2-isoprostanes are generated from arachidonic acid through a process of nonenzymatic free radical-catalyzed lipid peroxidation, thus representing an established marker of oxidative stress.33”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA direct antioxidant effect of polyphenols in vivo has been questioned because blood concentrations are low compared with other antioxidants and extensive metabolism after ingestion lowers their antioxidant activity.
“Indeed, a direct antioxidant effect of polyphenols in vivo has been questioned recently, because concentrations in blood are low compared with other antioxidants, and extensive metabolism after ingestion lowers their antioxidant activity.34”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationIt cannot be excluded that blood pressure reductions may contribute to supporting cognitive improvements and preventing blood pressure-related cognitive decline over a longer time course.
“However, we cannot exclude that these reductions in blood pressure, in addition to improving cardiovascular health, may contribute to supporting improvements in cognitive performance and even help in the prevention of blood pressure-related cognitive declines across a longer time course.31”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] source
Not checked in the free run.
May combine two claims.
PremisecitationFlavonoids improve nitric oxide bioavailability in the vasculature, which in turn plays a pivotal role in modulating cerebrovascular tone.
“In this regard, although we did not specifically evaluate the effect of cocoa flavanols on endothelial function, a number of studies, some also from our group, clearly demonstrated the ability of flavonoids to improve NO bioavailability in vasculature, 17,18,25 which, in turn, plays a pivotal role in modulating cerebrovascular tone.28”
Quote in the paperSubstantial claim0 of 4 sources checkedMay combine two claims.
InterpretationcitationExclusion of habitual consumers of dietary supplements with antioxidant properties likely did not affect the representativeness of the study population because consumption of these supplements among the elderly population is quite low, generally less than 10%, similar to other cohorts from the country.
“On the other hand, the exclusion of habitual consumers of dietary supplements with antioxidant properties likely did not affect the representativeness of our study population, because the consumption of these supplements among our elderly population is quite low, generally Ͻ10%, similar to that observed in other cohorts from our country.35”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe extent of the cognitive benefits, their duration, and their impact on the clinical course of MCI remain to be established because the intervention lasted two months.
“Second, because our study consisted of a 2-month intervention, the extent of the cognitive benefits and their duration, as well as their impact on a clinical course of MCI, remain to be established.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study did not specifically evaluate the effect of cocoa flavanols on endothelial function.
“In this regard, although we did not specifically evaluate the effect of cocoa flavanols on endothelial function, a number of studies, some also from our group, clearly demonstrated the ability of flavonoids to improve NO bioavailability in vasculature, 17,18,25 which, in turn, plays a pivotal role in modulating cerebrovascular tone.28”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStandard MCI criteria do not define optimal tests to establish cognitive performance in subjects with MCI.
“First, because standard MCI criteria do not define optimal tests to establish cognitive performance in subjects with MCI, 22 cognitive testing was performed using a battery of well-validated, standardized, and widely used neuropsychological tests exploring only some aspects of the complex cognitive dysfunction in subjects with MCI.1,2”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] source
Not checked in the free run.
The paper relies on this without support.
No dietary intervention study had yet specifically investigated neurocognitive performance in response to dietary flavanols in subjects with MCI.
“To the best of our knowledge, no dietary intervention study has yet specifically investigated the topic of neurocognitive performance in response to dietary flavanols in subjects with MCI.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dietary polyphenols from sources including cocoa and dealcoholized red wine are linked to improved vascular function.
“Dietary interventions have indicated improved vascular function linked to the consumption of polyphenols from different sources, including cocoa and dealcoholized red wine (60, 168, 225, 417, 834).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [225]
Cites
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025 · see citing works
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · see citing works
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811 · see citing works
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065 · see citing works
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works
Brain foods: The effects of nutrients on brain function.
Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372 · see citing works
Borkowski, J. G., Benton, A. L., & Spreen, O. (1967) · Neuropsychologia · doi:10.1016/0028-3932(67)90015-2 · Cited by 1,324 · see citing works
(–)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans
Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P., Keen, C. L., Hollenberg, N. K., Sies, H., Kwik-Uribe, C., Schmitz, H. H., & Kelm, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510168103 · Cited by 1,052 · see citing works
Self-citationDepression and memory impairment: A meta-analysis of the association, its pattern, and specificity.
Burt, D. B., Zembar, M. J., & Niederehe, G. (1995) · Psychological Bulletin · doi:10.1037/0033-2909.117.2.285 · Cited by 903 · see citing works
Intake of flavonoids and risk of dementia
Commenges, D., Scotet, V., Renaud, S., Jacqmin‐Gadda, H., Barberger‐Gateau, P., & Dartigues, J. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007614613771 · Cited by 647 · see citing works
Hypertension Is Related to Cognitive Impairment: A 20-Year Follow-up of 999 Men
Kilander, L., Nyman, H., Boberg, M., Hansson, L., & Lithell, H. (1998) · Hypertension · doi:10.1161/01.hyp.31.3.780 · Cited by 630 · see citing works
Hooper, L., Kay, C., Abdelhamid, A., Kroon, P. A., Cohn, J. S., Rimm, E. B., & Cassidy, A. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.023457 · Cited by 610 · see citing works
Grassi, D., Necozione, S., Lippi, C., Croce, G., Valeri, L., Pasqualetti, P., Desideri, G., Blumberg, J. B., & Ferri, C. (2005) · Hypertension · doi:10.1161/01.hyp.0000174990.46027.70 · Cited by 546 · see citing works
Self-citationVascular risk factors, incidence of MCI, and rates of progression to dementia
Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530 · see citing works
Flavonoid Intake and Cognitive Decline over a 10-Year Period
Letenneur, L., Proust‐Lima, C., Gouge, A. L., Dartigues, J. F., & Barberger‐Gateau, P. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm036 · Cited by 484 · see citing works
Grassi, D., Desideri, G., Necozione, S., Lippi, C., Casale, R., Properzi, G., Blumberg, J. B., & Ferri, C. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.9.1671 · Cited by 481 · see citing works
Self-citationIsoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
Patrono, C., & FitzGerald, G. A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2309 · Cited by 453 · see citing works
Williams, R. J., & Spencer, J. P. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.010 · Cited by 448 · see citing works
Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project
Kuriyama, S., Hozawa, A., Ohmori, K., Shimazu, T., Matsui, T., Ebihara, S., Awata, S., Nagatomi, R., Arai, H., & Tsuji, I. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.355 · Cited by 428 · see citing works
Hollman, P. C. H., Cassidy, A., Comte, B., Heinonen, M., Richelle, M., Richling, E., Serafini, M., Scalbert, A., Sies, H., & Vidry, S. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.131490 · Cited by 406 · see citing works
Cognitive function, dementia and type 2 diabetes mellitus in the elderly
Strachan, M. W. J., Reynolds, R. M., Marioni, R. E., & Price, J. F. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.228 · Cited by 402 · see citing works
Insulin resistance and Alzheimer's disease
De La Monte, S. M. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.8.475 · Cited by 392 · see citing works
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367 · see citing works
Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J., Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., & Zhou, H. D. (2011) · Neurology · doi:10.1212/wnl.0b013e318217e7a4 · Cited by 367 · see citing works
Krikorian, R., Nash, T. A., Shidler, M. D., Shukitt-Hale, B., & Joseph, J. A. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114509992364 · Cited by 353 · see citing works
The Effect of Flavanol-rich Cocoa on the fMRI Response to a Cognitive Task in Healthy Young People
Francis, S., Head, K., Morris, P. G., & Macdonald, I. A. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200606001-00018 · Cited by 314 · see citing works
The relationship between blood pressure and cognitive function
Novak, V., & Hajjar, I. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.161 · Cited by 299 · see citing works
Nurk, E., Refsum, H., Drevon, C. A., Tell, G. S., Nygaard, H. A., Engedal, K., & Smith, A. D. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.095182 · Cited by 261 · cited 1× · see citing works
“widely present in plant-based foods, may be associated with a decreased risk of incident dementia(5) and with a lower prevalence of cognitive impairment,(6) a better cognitive evolution over a 10-year period,(7) and better dose-dependent performance of several cognitive abilities in elderly subjects.(8)”
BackgroundSkeie, G., Braaten, T., Hjartåker, A., Lentjes, M., Amiano, P., Jakszyn, P., Pala, V, Palanca, A., Niekerk, E. M., Verhagen, H., et al. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.83 · Cited by 242 · see citing works
Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications
Neumann, K., Rojo, L., Navarrete, L., Farias, G., Reyes, P., & Maccioni, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508785908919 · Cited by 236 · see citing works
Endothelial influences on cerebrovascular tone
Andresen, J., Shafi, N. I., & Bryan, R. M. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00937.2005 · Cited by 235 · see citing works
Heiss, C., Jahn, S., Taylor, M., Real, W. M., Angeli, F. S., Wong, M. L., Amabile, N., Prasad, M., Rassaf, T., Ottaviani, J. I., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.039 · Cited by 202 · see citing works
Curtis, P. J., Sampson, M., Potter, J., Dhatariya, K., Kroon, P. A., & Cassidy, A. (2012) · Diabetes Care · doi:10.2337/dc11-1443 · Cited by 200 · see citing works
Macready, A. L., Kennedy, O. B., Ellis, J. A., Williams, C. M., Spencer, J. P. E., & Butler, L. T. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0135-4 · Cited by 198 · see citing works
Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans
PhD, F. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2310 · Cited by 162 · see citing works
Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans-1
Sorond, F. A., Lipsitz, L. A., Hollenberg, N. K., & Fisher, N. D. L. (2011) · Figshare · doi:10.6084/m9.figshare.87623 · Cited by 109 · see citing works
Abbatecola, A. M., Lattanzio, F., Molinari, A. M., Cioffi, M., Mansi, L., Rambaldi, P., DiCioccio, L., Cacciapuoti, F., Canonico, R., & Paolisso, G. (2010) · Diabetes Care · doi:10.2337/dc09-2030 · Cited by 93 · see citing works
Egan, B. M., Laken, M. A., Donovan, J. L., & Woolson, R. F. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.151522 · Cited by 38 · see citing works
Gaddi, A. V., Cicero, A. F. G., Wani, F. O., Dormi, A., Pasquarelli, V., & D’Addato, S. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601123 · Cited by 36 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The effects of polyphenols and other bioactives on human health
Fraga, C. G., Croft, K. D., Kennedy, D. O., & Tomás-Barberán, F. A. (2019) · Food & Function · doi:10.1039/c8fo01997e · Cited by 1,150 · see citing works
Rodriguez‐Mateos, A., Vauzour, D., Krueger, C. G., Shanmuganayagam, D., Reed, J. D., Calani, L., Mena, P. R., Rio, D. D., & Crozier, A. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1330-7 · Cited by 608 · see citing works
Williamson, G., Kay, C. D., & Crozier, A. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12351 · Cited by 607 · see citing works
Strategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576 · see citing works
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works
Flavor Chemistry of Cocoa and Cocoa Products—An Overview
Aprotosoaie, A. C., Luca, S. V., & Miron, A. (2015) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12180 · Cited by 507 · see citing works
Flavonoids and their role in oxidative stress, inflammation, and human diseases
Jomová, K., Alomar, S. Y., Valko, R., Líška, J., Nepovimová, E., Kuča, K., & Valko, M. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111489 · Cited by 413 · see citing works
Mastroiacovo, D., Kwik-Uribe, C. L., Grassi, D., Necozione, S., Raffaele, A., Pistacchio, L., Righetti, R., Bocale, R., Lechiara, M. C., Marini, C., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.092189 · Cited by 344 · see citing works
Self-citationRémond, D., Shahar, D. R., Gille, D., Pinto, P., Kachal, J., Peyron, M., dos Santos, C. N., Walther, B., Bordoni, A., Dupont, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4030 · Cited by 334 · see citing works
Andrieu, S., Coley, N., Lovestone, S., Aisen, P. S., & Vellas, B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00153-2 · Cited by 293 · see citing works
Lifestyle Medicine: The Health Promoting Power of Daily Habits and Practices
Rippe, J. M. (2018) · American Journal of Lifestyle Medicine · doi:10.1177/1559827618785554 · Cited by 305 · see citing works
Effect of cocoa on blood pressure
Ried, K., Fakler, P., & Stocks, N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008893.pub3 · Cited by 278 · see citing works
Ottaviani, J. I., Borges, G., Momma, T. Y., Spencer, J. P. E., Keen, C. L., Crozier, A., & Schroeter, H. (2016) · Scientific Reports · doi:10.1038/srep29034 · Cited by 256 · see citing works
Hwang, Y., Park, S., Paik, J., Chae, S., Kim, D., Jeong, D., Ha, E., Kim, M., Hong, G., Park, S., et al. (2019) · Nutrients · doi:10.3390/nu11020305 · Cited by 258 · see citing works
Linguistic Diversity and Traffic Accidents: Lessons from Statistical Studies of Cultural Traits
Roberts, S. G., & Winters, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070902 · Cited by 241 · see citing works
Therapies for Prevention and Treatment of Alzheimer’s Disease
Mendiola-Precoma, J., Berumen, L. C., Padilla, K., & García‐Alcocer, G. (2016) · BioMed Research International · doi:10.1155/2016/2589276 · Cited by 245 · see citing works
van Dam, R. M., Naidoo, N., & Landberg, R. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835bcdff · Cited by 212 · see citing works
Chocolate Consumption, Cognitive Function, and Nobel Laureates
Messerli, F. H. (2012) · New England Journal of Medicine · doi:10.1056/nejmon1211064 · Cited by 206 · see citing works
Rees, A., Dodd, G. F., & Spencer, J. P. E. (2018) · Nutrients · doi:10.3390/nu10121852 · Cited by 196 · see citing works
Psychosocial Risk Factors for Hypertension: an Update of the Literature
Cuffee, Y., Ogedegbe, C., Williams, N. J., Ogedegbe, G., & Schoenthaler, A. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0483-3 · Cited by 182 · see citing works
Sansone, R., Rodriguez‐Mateos, A., Heuel, J., Falk, D., Schuler, D., Wagstaff, R., Kuhnle, G., Spencer, J. P. E., Schroeter, H., Merx, M. W., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002822 · Cited by 178 · see citing works
The mechanisms of action of flavonoids in the brain: Direct versus indirect effects
Rendeiro, C., Rhodes, J. S., & Spencer, J. P. E. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.002 · Cited by 182 · see citing works
Chocolate and the brain: Neurobiological impact of cocoa flavanols on cognition and behavior
Sokolov, A. N., Pavlova, M. A., Klosterhalfen, S., & Enck, P. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.013 · Cited by 178 · see citing works
Enhancing Human Cognition with Cocoa Flavonoids
Socci, V., Tempesta, D., Desideri, G., de Gennaro, L., & Ferrara, M. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00019 · Cited by 141 · see citing works
Self-citationCenit, M. C., Nuevo, I. C., Codoñer-Franch, P., Dinan, T. G., & Sanz, Y. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-0969-z · Cited by 163 · see citing works
Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults
Wong, R. H. X., Berry, N. M., Coates, A. M., Buckley, J. D., Bryan, J., Kunz, I., & Howe, P. R. C. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328362b9d6 · Cited by 162 · see citing works
Sikkes, S. A. M., Tang, Y., Jutten, R. J., Wesselman, L. M. P., Turkstra, L. S., Brodaty, H., Clare, L., Cassidy‐Eagle, E. L., Cox, K. L., Chételat, G., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12188 · Cited by 154 · see citing works
Lin, X., Zhang, I., Li, A., Manson, J. E., Sesso, H. D., Wang, L., & Liu, S. (2016) · The Journal of Nutrition · doi:10.3945/jn.116.237644 · Cited by 150 · see citing works
Polyphenols and neuroprotection: therapeutic implications for cognitive decline
Caruso, G., Torrisi, S. A., Mogavero, M. P., Currenti, W., Castellano, S., Godos, J., Ferri, R., Galvano, F., Leggio, G. M., Grosso, G., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108013 · Cited by 140 · see citing works
Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people
Sorond, F. A., Hurwitz, S., Salat, D. H., Greve, D. N., & Fisher, N. D. L. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a351aa · Cited by 137 · see citing works
Vauzour, D. (2013) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6473 · Cited by 136 · see citing works
Tomé‐Carneiro, J., & Visioli, F. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.10.018 · Cited by 132 · see citing works
Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders
Farzaei, M. H., Singh, A. K., Kumar, R., Croley, C. R., Pandey, A. K., Coy-Barrera, E. D., Patra, J. K., Das, G., Kerry, R. G., Annunziata, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194957 · Cited by 134 · see citing works
Aguilera, Y., Martin-Cabrejas, M. A., & de Mejı́a, E. G. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-015-9443-z · Cited by 129 · see citing works
Lamport, D. J., Pal, D., Moutsiana, C., Field, D. T., Williams, C. M., Spencer, J. P. E., & Butler, L. T. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3972-4 · Cited by 126 · see citing works
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges
Davinelli, S., Maes, M., Corbi, G., Zarrelli, A., Willcox, D. C., & Scapagnini, G. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0070-3 · Cited by 122 · see citing works
Neshatdoust, S., Saunders, C., Castle, S. M., Vauzour, D., Williams, C. M., Butler, L. T., Lovegrove, J. A., & Spencer, J. P. E. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-1615 · Cited by 123 · see citing works
Jayasena, T., Poljak, A., Smythe, G. A., Braidy, N., Münch, G. W., & Sachdev, P. S. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.06.003 · Cited by 120 · see citing works
Kennedy, D. O. (2014) · Advances in Nutrition · doi:10.3945/an.114.006320 · Cited by 125 · see citing works
Dark chocolate: An overview of its biological activity, processing, and fortification approaches
Samanta, S., Sarkar, T., Chakraborty, R., Ребезов, М. Б., Shariati, M. A., Thiruvengadam, M., & Rengasamy, K. R. R. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.10.017 · Cited by 117 · see citing works
Effects of Polyphenols on Insulin Resistance
Williamson, G., & Sheedy, K. (2020) · Nutrients · doi:10.3390/nu12103135 · Cited by 120 · see citing works
Flanagan, E. C., Müller, M. M., Hornberger, M., & Vauzour, D. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0226-1 · Cited by 115 · see citing works
Mannino, G., Chinigò, G., Serio, G., Genova, T., Gentile, C., Munaron, L., & Bertea, C. M. (2021) · Antioxidants · doi:10.3390/antiox10081229 · Cited by 111 · see citing works
Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease
Camandola, S., Plick, N., & Mattson, M. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2492-0 · Cited by 89 · see citing works
The Gut Microbiota Links Dietary Polyphenols With Management of Psychiatric Mood Disorders
Westfall, S., & Pasinetti, G. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01196 · Cited by 108 · see citing works
The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach
Isaacson, R., Ganzer, C. A., Hristov, H., Hackett, K., Caesar, E. E., Cohen, R. E., Kachko, R., Meléndez‐Cabrero, J., Rahman, A., Scheyer, O., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.08.004 · Cited by 103 · see citing works
Rao, R. V., Subramaniam, K. G., Gregory, J., Bredesen, A. L., Coward, C., Okada, S., Kelly, L., & Bredesen, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021659 · Cited by 105 · see citing works
The hypoglycemic potential of phenolics from functional foods and their mechanisms
Головинская, О., & Wang, C. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.10.020 · Cited by 99 · see citing works
Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases
Forte, M., Conti, V., Damato, A., Ambrosio, M., Puca, A. A., Sciarretta, S., Frati, G., Vecchione, C., & Carrizzo, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7364138 · Cited by 96 · see citing works
Impact of cocoa flavanols on human health
Martín, M. Á., & Ramos, S. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112121 · Cited by 97 · see citing works
Goya, L., Kongor, J. E., & de Pascual‐Teresa, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214365 · Cited by 97 · see citing works
Effect of Fermentation and Drying on Cocoa Polyphenols
Albertini, B., Schoubben, A., Guarnaccia, D., Pinelli, F., Vecchia, M. D., Ricci, M., Renzo, G. C. D., & Blasi, P. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b01062 · Cited by 94 · see citing works
Massee, L. A., Ried, K., Pase, M. P., Travica, N., Yoganathan, J., Scholey, A. B., Macpherson, H., Kennedy, G., Sali, A., & Pipingas, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00093 · Cited by 93 · see citing works
Mechanisms by which cocoa flavanols improve metabolic syndrome and related disorders
Strat, K. M., Rowley, T. J., Smithson, A. T., Tessem, J. S., Hulver, M. W., Liu, D., Davy, B. M., Davy, K. P., & Neilson, A. P. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.12.008 · Cited by 92 · see citing works
Chen, L., Pu, Y., Xü, Y., He, X., Cao, J., Ma, Y., & Jiang, W. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111202 · Cited by 91 · see citing works
The protective effects of polyphenols on Alzheimer's disease: A systematic review
Colizzi, C. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.09.002 · Cited by 93 · see citing works
Angelino, D., Carregosa, D., Domenech-Coca, C., Savi, M., Figueira, I., Brindani, N., Jang, S., Lakshman, S., Molokin, A., Urban, J. F., et al. (2019) · Nutrients · doi:10.3390/nu11112678 · Cited by 89 · see citing works
Diet and lifestyle impact the development and progression of Alzheimer’s dementia
Arora, S., Santiago, J. A., Bernstein, M., & Potashkin, J. A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1213223 · Cited by 96 · see citing works
Rodriguez-Mateos, A., Hezel, M., Aydin, H., Kelm, M., Lundberg, J. O., Weitzberg, E., Spencer, J. P. E., & Heiss, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.009 · Cited by 88 · see citing works
Effects of cocoa extract and a multivitamin on cognitive function: a randomized clinical trial
Baker, L. D., Manson, J. E., Rapp, S. R., Sesso, H. D., Gaussoin, S. A., Shumaker, S. A., & Espeland, M. A. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12767 · Cited by 88 · see citing works
Effect of dietary interventions in mild cognitive impairment: a systematic review
McGrattan, A., McEvoy, C. T., McGuinness, B., McKinley, M. C., & Woodside, J. V. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518002945 · Cited by 81 · see citing works
Cimini, A., Gentile, R., D’Angelo, B., Benedetti, E., Cristiano, L., Avantaggiati, M. L., Giordano, A., Ferri, C., & Desideri, G. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24548 · Cited by 80 · see citing works
Self-citationThe mediation role of sleep quality in the relationship between cognitive decline and depression
Liu, X., Xia, X., Hu, F., Hao, Q., Hou, L., Sun, X., Zhang, G., Yue, J., & Dong, B. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02855-5 · Cited by 79 · see citing works
Vitale, M., Vaccaro, O., Masulli, M., Bonora, E., Prato, S. D., Giorda, C. B., Nicolucci, A., Squatrito, S., Auciello, S., Babini, A. C., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.11.002 · Cited by 78 · see citing works
Dietary Flavonoids and Human Cognition: A Meta‐Analysis
Cheng, N., Bell, L., Lamport, D. J., & Williams, C. M. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100976 · Cited by 75 · see citing works
Microbiome in brain function and mental health
Kennedy, P. J., Murphy, A., Cryan, J. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.05.001 · Cited by 76 · see citing works
The Cardiovascular Effects of Cocoa Polyphenols—An Overview
Aprotosoaie, A. C., Miron, A., Trifan, A., Luca, V., & Costache, I. I. (2016) · Diseases · doi:10.3390/diseases4040039 · Cited by 74 · see citing works
Ettcheto, M., Cano, A., Manzine, P. R., Busquets, O., Verdaguer, E., Castro-Torres, R. D., García, M. L., Beas-Zarate, C., Olloquequi, J., Auladell, C., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01849-6 · Cited by 73 · see citing works
Chocolate Consumption is Associated with a Lower Risk of Cognitive Decline
Moreira, A. M. D. S., Diógenes, M. J., de Mendonça, A., Lunet, N., & Barros, H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160142 · Cited by 73 · see citing works
Roberts, S. B., Franceschini, M. A., Silver, R. E., Taylor, S. F., de Sa, A. B., Có, R., Sonco, A., Krauss, A. J., Taetzsch, A., Webb, P., et al. (2020) · BMJ · doi:10.1136/bmj.m2397 · Cited by 71 · see citing works
Taub, P. R., Ramírez‐Sánchez, I., Patel, M., Higginbotham, E., Moreno‐Ulloa, A., Román-Pintos, L. M., Phillips, P., Perkins, G. A., Ceballos, G. M., & Villarreal, F. J. (2016) · Food & Function · doi:10.1039/c6fo00611f · Cited by 71 · see citing works
The Impact of Epicatechin on Human Cognition: The Role of Cerebral Blood Flow
Haskell‐Ramsay, C. F., Schmitt, J. A. J., & Actis‐Goretta, L. (2018) · Nutrients · doi:10.3390/nu10080986 · Cited by 70 · see citing works
Botanicals and phytochemicals active on cognitive decline: The clinical evidence
Cicero, A. F. G., Fogacci, F., & Banach, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.029 · Cited by 70 · see citing works
Grassi, D., Socci, V., Tempesta, D., Ferri, C., Gennaro, L. D., Desideri, G., & Ferrara, M. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000926 · Cited by 67 · see citing works
Self-citationPotential role of phytochemicals in metabolic syndrome prevention and therapy
Francini, F.-P., Spinella, P., & Calò, L. A. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s214550 · Cited by 74 · see citing works
Nutraceuticals for blood pressure control
Sirtori, C., Arnoldi, A., & Cicero, A. (2015) · Annals medicus · doi:10.3109/07853890.2015.1078905 · Cited by 40 · see citing works
Dal‐Pan, A., Dudonné, S., Bourassa, P., Bourdoulous, M., Tremblay, C., Desjardins, Y., & Calon, F. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160281 · Cited by 62 · see citing works
González‐Sarrías, A., Combet, E., Pinto, P., Mena, P. R., Dall’Asta, M., Garcia‐Aloy, M., Rodriguez‐Mateos, A., Gibney, E. R., Dumont, J., Massaro, M., et al. (2017) · Nutrients · doi:10.3390/nu9070746 · Cited by 64 · see citing works
Baião, D. D. S., Freitas, C. D., Gomes, L. P., Silva, D. D., Corrêa, A. C. N. T. F., Pereira, P. R., Aguila, E. M. D., & Paschoalin, V. M. F. (2017) · Nutrients · doi:10.3390/nu9091044 · Cited by 62 · see citing works
(–)‐Epicatechin in the control of glucose homeostasis: Involvement of redox‐regulated mechanisms
Cremonini, E., Fraga, C., & Oteiza, P. (2019) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2018.11.010 · Cited by 54 · see citing works
Coley, N., Giulioli, C., Aisen, P. S., Vellas, B., & Andrieu, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101777 · Cited by 62 · see citing works
Effect of Cocoa and Cocoa Products on Cognitive Performance in Young Adults
Martín, M. Á., Goya, L., & de Pascual‐Teresa, S. (2020) · Nutrients · doi:10.3390/nu12123691 · Cited by 63 · see citing works
Wade, A. T., Davis, C. R., Dyer, K. A., Hodgson, J. M., Woodman, R. J., Keage, H. A. D., & Murphy, K. J. (2019) · Nutrients · doi:10.3390/nu11071521 · Cited by 60 · see citing works
Lamport, D. J., & Williams, C. M. (2020) · Brain Plasticity · doi:10.3233/bpl-200111 · Cited by 59 · see citing works
Wang, J., Varghese, M., Ono, K., Yamada, M., Levine, S., Tzavaras, N., Gong, B., Hurst, W. J., Blitzer, R. D., & Pasinetti, G. M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132231 · Cited by 58 · see citing works
Wightman, E. L., Jackson, P. A., Khan, J., Forster, J. S., Heiner, F., Feistel, B., Suarez, C. G., Pischel, I., & Kennedy, D. O. (2018) · Nutrients · doi:10.3390/nu10080955 · Cited by 58 · see citing works
Schuster, J., & Mitchell, E. S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.09.005 · Cited by 58 · see citing works
Acute effects of flavonoid-rich blueberry on cognitive and vascular function in healthy older adults
Dodd, G. F., Williams, C. M., Butler, L. T., & Spencer, J. P. E. (2019) · Nutrition and Healthy Aging · doi:10.3233/nha-180056 · Cited by 54 · see citing works
Ottaviani, J. I., Balz, M., Kimball, J., Ensunsa, J. L., Fong, R. Y., Momma, T. Y., Kwik-Uribe, C. L., Schroeter, H., & Keen, C. L. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.116178 · Cited by 54 · see citing works
Self-citationDietary flavonoid intake at midlife and healthy aging in women
Samieri, C., Sun, Q., Townsend, M. K., Rimm, E. B., & Grodstein, F. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.085605 · Cited by 53 · see citing works
Kennedy, D. O. (2019) · Sports Medicine · doi:10.1007/s40279-018-1007-0 · Cited by 58 · see citing works
Sloan, R. P., Wall, M. M., Yeung, L., Feng, T., Feng, X., Provenzano, F. A., Schroeter, H., Lauriola, V., Brickman, A. M., & Small, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-83370-2 · Cited by 53 · see citing works
Protective effects of dark chocolate on endothelial function and diabetes
Grassi, D., Desideri, G., & Ferri, C. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283659a51 · Cited by 52 · see citing works
Self-citationYang, W., Cui, K., Li, X., Zhao, J., Zeng, Z., Song, R., Qi, X., & Xu, W. (2021) · The journal of nutrition health & aging · doi:10.1007/s12603-021-1685-4 · Cited by 53 · see citing works
Barrera‐Reyes, P. K., de Lara, J. C.-F., Gonzalez‐Soto, M., & Tejero, M. E. (2020) · Plant Foods for Human Nutrition · doi:10.1007/s11130-019-00779-x · Cited by 51 · see citing works
Mental Performance and Sport: Caffeine and Co-Consumed Bioactive Ingredients
Kennedy, D. O., & Wightman, E. L. (2022) · Sports Medicine · doi:10.1007/s40279-022-01796-8 · Cited by 50 · see citing works
“Longer-term supplementation with cocoa-flavanol extracts for 4 weeks also increased attention and executive function task performance, alongside beneficial effects on multiple biomarkers of health, in 90 heathy elderly [125] and 90 sufferers from age-related cognitive impairment [126].”
BackgroundAnti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging
Martínez‐Coria, H., Arrieta‐Cruz, I., Juárez, R. G., & López-Valdés, H. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054297 · Cited by 51 · see citing works
Nootropics, Functional Foods, and Dietary Patterns for Prevention of Cognitive Decline
Bonetti, F., Brombo, G., & Zuliani, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805376-8.00019-8 · Cited by 49 · see citing works
Clifford, T., Babateen, A. M., Shannon, O. M., Capper, T. E., Ashor, A. W., Stephan, B. C. M., Robinson, L. A., O'Hara, J. P., Mathers, J. C., Stevenson, E., et al. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1453779 · Cited by 49 · see citing works
Verburgh, K. (2014) · Aging Cell · doi:10.1111/acel.12284 · Cited by 48 · see citing works
- Authors
- Desideri, G., Kwik-Uribe, C., Grassi, D., Necozione, S., Ghiadoni, L., Mastroiacovo, D., Raffaele, A., Ferri, L., Bocale, R., Lechiara, M. C., Marini, C., & Ferri, C.
- Affiliations
- University of Pisa (IT)
- ORCID
- Venue
- Hypertension
- Published
- 2012-09
- Volume
- 60
- Issue
- 3
- Pages
- 794-801
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2157857601
- Semantic Scholar
- b5ec6c4ca070b47009785a99a925182aa2a856b6
- Cited by
- 311
- References
- 41
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 21 · 2023: 25 · 2022: 30 · 2021: 18 · 2020: 23 · 2019: 24 · 2018: 30 · 2017: 21 · 2016: 23 · 2015: 25 · 2014: 14 · 2013: 22 · 2012: 4
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- cocoa flavanols, mild cognitive impairment, cognitive function, older adults, insulin resistance, blood pressure, lipid peroxidation, dietary intervention, Trail Making Test, verbal fluency, Mini-Mental State Examination
- MeSH terms
- Aged, Aged, 80 and over, Aging, Blood Pressure, Cacao, Cognition, Cognition Disorders, Dose-Response Relationship, Drug, Double-Blind Method, Eating, Female, Follow-Up Studies, Humans, Insulin Resistance, Intelligence Tests, Male, Middle Aged, Lipid Peroxidation, Treatment Outcome, Flavanones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review